ArticleJournal of cell science2026
The acyl- and alkyl-glycerone phosphate reductase DHRS7 is involved in the production of distinct plasmalogen species from DHRS7B.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Plasmalogens are ether lipids that constitute mammalian membranes. In their biosynthetic pathway, DHRS7B functions as an alkylglycerone phosphate reductase. Here, we have investigated whether DHRS7, which shares high sequence similarity with DHRS7B, also contributes to plasmalogen production. We generated DHRS7 and DHRS7B knockout (KO) cells, as well as double-KO cells, and quantified ethanolamine plasmalogens (PE[P]s). DHRS7 and DHRS7B were involved in the production of distinct fatty acid species: in the de novo synthesis pathway, DHRS7 contributed most strongly to the synthesis of C18:1 species, followed by C16:0 and C22:4 species, whereas DHRS7B contributed to the synthesis of all species examined. These differences in contribution in the de novo pathway resulted in further differences in the steady-state composition of PE[P]s. DHRS7 and DHRS7B also showed different intracellular localization: endoplasmic reticulum for DHRS7 and peroxisomes for DHRS7B. In vitro, DHRS7 exhibited both alkyl- and acyl-glycerone phosphate reductase activities, similar to DHRS7B. Collectively, our findings indicate that DHRS7 is a previously unreported acyl- and alkyl-glycerone (acyl/alkyl-glycerone) phosphate reductase that differs from DHRS7B in both subcellular localization and the profile of plasmalogen species produced.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.